Page last updated: 2024-09-04

naproxen and tarenflurbil

naproxen has been researched along with tarenflurbil in 2 studies

Compound Research Comparison

Studies (naproxen)	Trials (naproxen)	Recent Studies (post-2010) (naproxen)	Studies (tarenflurbil)	Trials (tarenflurbil)	Recent Studies (post-2010) (tarenflurbil)
4,551	1,057	1,429	37	1	21

Protein Interaction Comparison

Protein	Taxonomy	naproxen (IC50)	tarenflurbil (IC50)
Prostaglandin G/H synthase 2	Mus musculus (house mouse)		1.3

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Allegretti, M; Berdini, V; Bertini, R; Bizzarri, C; Cesta, MC; Colotta, F; Di Bello, N; Di Bitondo, R; Di Cioccio, V; Fantucci, P; Florio, S; Galliera, E; Locati, M; Nano, G; Nicolini, L; Russo, V; Topai, A; Zampella, G	1
Bain, G; Beher, D; Chen, W; Jiang, X; Munoz, B; Peachey, J; Prasit, P; Shearman, MS; St-Jacques, R; Stock, N; Williamson, TL; Wrigley, JD	1

Other Studies

2 other study(ies) available for naproxen and tarenflurbil

Article	Year
2-Arylpropionic CXC chemokine receptor 1 (CXCR1) ligands as novel noncompetitive CXCL8 inhibitors. Journal of medicinal chemistry, 2005, Jun-30, Volume: 48, Issue:13 Topics: Animals; Binding Sites; Cell Line, Tumor; Cell Movement; Chemokines, CXC; Chemotaxis, Leukocyte; Female; Humans; Ketoprofen; Ligands; Lymphoma; Macrophages, Peritoneal; Mice; Models, Molecular; Mutagenesis, Site-Directed; Propionates; Receptors, Interleukin-8A; Recombinant Proteins; Structure-Activity Relationship	2005
The geminal dimethyl analogue of Flurbiprofen as a novel Abeta42 inhibitor and potential Alzheimer's disease modifying agent. Bioorganic & medicinal chemistry letters, 2006, Apr-15, Volume: 16, Issue:8 Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain; Cyclooxygenase Inhibitors; Disease Models, Animal; Flurbiprofen; Mice; Peptide Fragments	2006

Article

Year

2-Arylpropionic CXC chemokine receptor 1 (CXCR1) ligands as novel noncompetitive CXCL8 inhibitors.

Journal of medicinal chemistry, 2005, Jun-30, Volume: 48, Issue:13

Topics: Animals; Binding Sites; Cell Line, Tumor; Cell Movement; Chemokines, CXC; Chemotaxis, Leukocyte; Female; Humans; Ketoprofen; Ligands; Lymphoma; Macrophages, Peritoneal; Mice; Models, Molecular; Mutagenesis, Site-Directed; Propionates; Receptors, Interleukin-8A; Recombinant Proteins; Structure-Activity Relationship

2005

The geminal dimethyl analogue of Flurbiprofen as a novel Abeta42 inhibitor and potential Alzheimer's disease modifying agent.

Bioorganic & medicinal chemistry letters, 2006, Apr-15, Volume: 16, Issue:8

Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain; Cyclooxygenase Inhibitors; Disease Models, Animal; Flurbiprofen; Mice; Peptide Fragments

2006